Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.675 USD | +0.30% | -6.46% | -88.69% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.69% | 114M | |
-2.91% | 89.01B | |
-4.34% | 37.79B | |
-16.23% | 31.22B | |
+60.33% | 26.1B | |
-23.07% | 14.25B | |
-8.50% | 12.8B | |
-11.39% | 11.65B | |
+4.04% | 8.7B | |
-17.54% | 7.45B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Goldman Sachs Upgrades Amylyx Pharmaceuticals to Buy From Neutral, Adjusts Price Target to $49 From $45